Ophthalmic conditions are common in women of childbearing age, and treatments for these are evolving at a fast pace. When these women become pregnant, a common source of anxiety is both the potential continuation of these medications, as well as what the impact on pregnancy and delivery might be.
Directed by Charlotte Frise, Consultant Obstetric Physician based at Queen Charlotte's and Chelsea Hospital in London, and featuring leading speakers who are passionate about this topic, this course aims to cover all of these aspects in detail.
The course will be in hybrid format, with live presentations from speakers attending in person.
As a result of attending you will gain more detailed knowledge about:
Nuances of medication use in pregnancy including non-biological DMARDs, biological DMARDs and anti VEGF
Delivery considerations for women with eye disease
Pregnancy considerations in women with diabetic retinopathy
The structure of maternity care and the members of the wider multidisciplinary team
This course is intended for ophthalmologists from trainee to consultant level.
A certificate of attendance will be awarded at the end of the study day and CPD points will be applied for.
Date | Location | Time | Seats | Price | |
10 March 2025 | Education Hub, 15 Ebenezer Street, London N1 7NH | 45 | £245.00 | ||
10 March 2025 | Online via MS Teams | £165.00 |
Charlotte Frise is a consultant Obstetric Physician and is Lead Obstetric Physician for the NW London Maternal Medicine network. She is a senior college lecturer in Clinical Medicine at Keble College, Oxford. She is co-editor-in-chief of the journal Obstetric Medicine. She has also recently authored two textbooks: Obstetric Medicine, in the Oxford Specialist Handbooks in Obstetrics and Gynaecology series and Case Histories in Obstetric Medicine.
Dr Iona Thorne is a Consultant Obstetric Physician in the North West London Maternal Medicine Network, having swapped her rheumatology clinics for obstetric medicine clinics. She has established up the British Society of Rheumatology’s Special Interest Group for Obstetric Rheumatology, and co-led the recent Lancet Rheumatology series on Pregnancy and Rheumatic Disease.